Literature DB >> 17029708

Bistability and the species barrier in prion diseases: stepping across the threshold or not.

M Laurent1.   

Abstract

The infectious agent of transmissible spongiform encephalopathies is thought to be a cellular protein, the prion protein, which undergoes, under some circumstances, a dramatic conformational change leading to pathogenesis. The conversion between the normal and pathogenic isoforms corresponds to a autocatalytic mechanism and the metabolism of the prion protein exhibits switches between a normal, stable steady state and a pathogenic one. When the disease can be transmitted between two species, a primary infection from a heterologous donor has to be followed by two passages in the same host species so that the incubation period is stabilized. Sometimes, no pathogenic isoform of the prion protein is detected after the first passage, although corresponding brain extracts remain infectious. The observation that three and only three passages are needed in order to stabilize the strain strongly suggests that, during the course of the primary infection by the heterologous donor, an intermediary conformational species is formed. Within this assumption, a common mechanism involving only conformational changes of the prion protein can give a unifying interpretation of the problem of species barrier, lag characteristics and apparent lack of detection of the pathogenic isoform after the first passage in experiments dealing with interspecies transmission of prion diseases.

Entities:  

Year:  1998        PMID: 17029708     DOI: 10.1016/s0301-4622(98)00135-5

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  6 in total

Review 1.  The prion hypothesis: from biological anomaly to basic regulatory mechanism.

Authors:  Mick F Tuite; Tricia R Serio
Journal:  Nat Rev Mol Cell Biol       Date:  2010-11-17       Impact factor: 94.444

2.  Prion diseases: dynamics of the infection and properties of the bistable transition.

Authors:  N Kellershohn; M Laurent
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

3.  Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.

Authors:  N Kellershohn; M Laurent
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

4.  There is no safe dose of prions.

Authors:  Helen R Fryer; Angela R McLean
Journal:  PLoS One       Date:  2011-08-15       Impact factor: 3.240

5.  Estimation of the exposure of the UK population to the bovine spongiform encephalopathy agent through dietary intake during the period 1980 to 1996.

Authors:  Chu-Chih Chen; Yin-Han Wang
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

6.  Estimating relative CWD susceptibility and disease progression in farmed white-tailed deer with rare PRNP alleles.

Authors:  Nicholas J Haley; Kahla Merrett; Amy Buros Stein; Dennis Simpson; Andrew Carlson; Gordon Mitchell; Antanas Staskevicius; Tracy Nichols; Aaron D Lehmkuhl; Bruce V Thomsen
Journal:  PLoS One       Date:  2019-12-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.